Xpro India Limited (NSE:XPROINDIA)
India · Delayed Price · Currency is INR 1,111.40
+9.10 (0.83%)
Nov 11, 2026, 2:29 PM IST
Xpro India Revenue
Xpro India had revenue of 1.81B INR in the quarter ending September 30, 2026, with 50.67% growth. This brings the company's total for the last twelve months to 5.92B, up 12.26% year-over-year. In the fiscal year ending March 31, 2026, Xpro India had annual revenue of 5.05B, down -5.57%.
Revenue (ttm)
5.92B
Revenue Growth
+12.26%
P/S Ratio
4.34
Revenue / Employee
24.78M
Employees
239
Market Cap
26.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.05B | -297.93M | -5.57% |
| Mar 31, 2025 | 5.35B | 698.74M | 15.01% |
| Mar 31, 2024 | 4.65B | -455.59M | -8.92% |
| Mar 31, 2023 | 5.11B | 392.50M | 8.32% |
| Mar 31, 2022 | 4.72B | 983.66M | 26.35% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossari Biotech | 26.61B |
| S H Kelkar and Company | 25.31B |
| Veedol Corporation | 24.01B |
| Jubilant Agri and Consumer Products | 20.52B |
| NOCIL | 14.76B |
| Shree Pushkar Chemicals & Fertilisers | 11.52B |
| Advanced Enzyme Technologies | 7.82B |
| Tatva Chintan Pharma Chem | 6.50B |
Xpro India News
- 4 months ago - Xpro India announces 29th AGM and releases annual report for FY 2025-26 - Business Upturn
- 4 months ago - Xpro India announces 20% dividend per equity share with tax deduction details - Business Upturn